Alan Bash

Legend Biotech Corporation has appointed former Novartis commercial executive Ingrid Zhang as chief executive after a seven-week leadership search, putting an experienced global medicines operator in charge as CARVYKTI sales accelerate and the cell therapy company tries to build its next growth engine.